121 related articles for article (PubMed ID: 36950830)
1. Ormeloxifene, a nonsteroidal antifertility drug promotes megakaryocyte differentiation in leukemia cell line K562.
Mishra M; Singh AK; Thacker G; Upadhyay V; Sanyal S; Trivedi AK
Cell Biol Int; 2023 Jul; 47(7):1247-1258. PubMed ID: 36950830
[TBL] [Abstract][Full Text] [Related]
2. Nobiletin Promotes Megakaryocytic Differentiation through the MAPK/ERK-Dependent EGR1 Expression and Exerts Anti-Leukemic Effects in Human Chronic Myeloid Leukemia (CML) K562 Cells.
Yen JH; Lin CY; Chuang CH; Chin HK; Wu MJ; Chen PY
Cells; 2020 Apr; 9(4):. PubMed ID: 32260160
[TBL] [Abstract][Full Text] [Related]
3. Involvement of nPKC-MAPK pathway in the decrease of nucleophosmin/B23 during megakaryocytic differentiation of human myelogenous leukemia K562 cells.
Chou CC; Yung BY; Hsu CY
Life Sci; 2007 May; 80(22):2051-9. PubMed ID: 17448503
[TBL] [Abstract][Full Text] [Related]
4. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53.
Navarro F; Gutman D; Meire E; Cáceres M; Rigoutsos I; Bentwich Z; Lieberman J
Blood; 2009 Sep; 114(10):2181-92. PubMed ID: 19584398
[TBL] [Abstract][Full Text] [Related]
5. Naturally Occurring Bicoumarin Compound Daphnoretin Inhibits Growth and Induces Megakaryocytic Differentiation in Human Chronic Myeloid Leukemia Cells.
Huang YC; Huang CP; Lin CP; Yang KC; Lei YJ; Wang HP; Kuo YH; Chen YJ
Cells; 2022 Oct; 11(20):. PubMed ID: 36291120
[TBL] [Abstract][Full Text] [Related]
6. 2-(trimethylammonium)ethyl (R)-3-methoxy-3-oxo-2-stearamidopropyl phosphate promotes megakaryocytic differentiation of myeloid leukaemia cells and primary human CD34⁺ haematopoietic stem cells.
Limb JK; Song D; Jeon M; Han SY; Han G; Jhon GJ; Bae YS; Kim J
J Tissue Eng Regen Med; 2015 Apr; 9(4):435-46. PubMed ID: 23166016
[TBL] [Abstract][Full Text] [Related]
7. The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells.
Pettiford SM; Herbst R
Leukemia; 2003 Feb; 17(2):366-78. PubMed ID: 12592337
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl(+) K562 leukemic cells by Gab2.
Dorsey JF; Cunnick JM; Mane SM; Wu J
Blood; 2002 Feb; 99(4):1388-97. PubMed ID: 11830491
[TBL] [Abstract][Full Text] [Related]
9. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
10. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.
Elagib KE; Racke FK; Mogass M; Khetawat R; Delehanty LL; Goldfarb AN
Blood; 2003 Jun; 101(11):4333-41. PubMed ID: 12576332
[TBL] [Abstract][Full Text] [Related]
11. Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3.
Tringali C; Lupo B; Cirillo F; Papini N; Anastasia L; Lamorte G; Colombi P; Bresciani R; Monti E; Tettamanti G; Venerando B
Cell Death Differ; 2009 Jan; 16(1):164-74. PubMed ID: 18820643
[TBL] [Abstract][Full Text] [Related]
12. Effects of radiation on the maturation of megakaryocytes.
Hirose K; Monzen S; Yoshino H; Sato H; Aoki M; Hatayama Y; Kawaguchi H; Sato M; Narita Y; Takai Y; Kashiwakura I
J Radiat Res; 2013 May; 54(3):447-52. PubMed ID: 23297317
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of human NDR gene in megakaryocytic differentiation of erythroleukemia K562 cells.
Liu CC; Chou YL; Ch'ang LY
J Biomed Sci; 2004; 11(1):104-16. PubMed ID: 14730214
[TBL] [Abstract][Full Text] [Related]
14. Erythroid and megakaryocytic differentiation of K562 erythroleukemic cells by monochloramine.
Ogino T; Kobuchi H; Fujita H; Matsukawa A; Utsumi K
Free Radic Res; 2014 Mar; 48(3):292-302. PubMed ID: 24237253
[TBL] [Abstract][Full Text] [Related]
15. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation.
Shelly C; Petruzzelli L; Herrera R
Cell Growth Differ; 2000 Sep; 11(9):501-6. PubMed ID: 11007455
[TBL] [Abstract][Full Text] [Related]
16. Nerve growth factor potentiated the sodium butyrate- and PMA-induced megakaryocytic differentiation of K562 leukemia cells.
Xie P; Chan FS; Ip NY; Leung M
Leuk Res; 2000 Sep; 24(9):751-9. PubMed ID: 10978779
[TBL] [Abstract][Full Text] [Related]
17. The involvement of human-nuc gene in polyploidization of K562 cell line.
Cavalloni G; Danè A; Piacibello W; Bruno S; Lamas E; Bréchot C; Aglietta M
Exp Hematol; 2000 Dec; 28(12):1432-40. PubMed ID: 11146165
[TBL] [Abstract][Full Text] [Related]
18. Autophagy is an important event for megakaryocytic differentiation of the chronic myelogenous leukemia K562 cell line.
Colosetti P; Puissant A; Robert G; Luciano F; Jacquel A; Gounon P; Cassuto JP; Auberger P
Autophagy; 2009 Nov; 5(8):1092-8. PubMed ID: 19786835
[TBL] [Abstract][Full Text] [Related]
19. Effects of THAP11 on erythroid differentiation and megakaryocytic differentiation of K562 cells.
Kong XZ; Yin RH; Ning HM; Zheng WW; Dong XM; Yang Y; Xu FF; Li JJ; Zhan YQ; Yu M; Ge CH; Zhang JH; Chen H; Li CY; Yang XM
PLoS One; 2014; 9(3):e91557. PubMed ID: 24637716
[TBL] [Abstract][Full Text] [Related]
20. Protein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cells.
Chang YI; Hua WK; Yao CL; Hwang SM; Hung YC; Kuan CJ; Leou JS; Lin WJ
J Biol Chem; 2010 Jul; 285(27):20595-606. PubMed ID: 20442406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
